Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Lysophosphatidic acid (LPA), a phospholipid derivative that functions as a signalling molecule, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of its target gene, 8/April/2017, 10.50 pm

Natural product-derived therapy for glucose homeostasis and TIIDM: Isoliquiritigenin, one of the main components found in Licorice, increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of their target gene, 8/April/2017, 9.10 am
April 8, 2017
Natural product-derived antiviral therapy against Neuroinvasive West Nile virus: Luteolin, a flavonoid found in Salvia tomentosa, Perilla, thyme, among others, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 8/April/2017, 11.38 pm
April 8, 2017
Show all

Introduction: What they say

A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis regulates glucose metabolism.” This study was published in the 30 September  2011 issue of the Journal “Cell” [One of the best journals in Biological sciences with an I.F of 28.71]  by Prof and Dean of the Harvard Medical SchooGeorge Q, Zhu H, and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Lysophosphatidic acid (LPA), a phospholipid derivative that functions as a signalling molecule,  increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of  its target gene [easy_payment currency=”USD”]

Price 100


From significance of the study to Public health relevance

Given that: (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) Diabetes is going to be one of the top 10 causes of death by 2030; (3) the life-long painful injection/drug treatment is required to treat DM; (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult ß-cells and cardiomyocytes that were lost in DM (Diabetes Mellitus) and MI (Myocardial infarction), respectively; (ii) a cheaper alternative to the existing expensive weight-loss drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, diabetes.


What is known?

Prof. George Q and his research team members had shown earlier that loss of Lin28 in muscles promotes insulin resistance and glucose intolerance. 


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, that Lysophosphatidic acid (LPA), by regulating the expression of its target genesit may (1) increase the expression of IGF1R, INSR, and IRS2; (2) enhance tissue repair; (3) promote regeneration of pancreatic β-cells; (3) augment regenerative capacity; (4) promote insulin sensitivity; and (5) protect against cardiac ageing and dilated cardiomyopathy (DCM) (Fig.1).

Lysophosphatidic acid induces lin28 experssion and promotes insulin sensitivity

Figure 1. Mechanistic insights into how Lysophosphatidic acid (LPA) functions as an anti-diabetic and a cardioprotective agent. Lysophosphatidic acid (LPA) may promote insulin sensitivity and protect against myocardial infarction via up regulation of reprogramming protein Lin-28

Thus, pharmacological formulations encompassing Lysophosphatidic acid (LPA) or its analogues either alone or in combination with other drugs” may be used to treat DM and DCM.


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $ 100 #

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Lysophosphatidic acid (LPA) promote insulin-sensitized state?

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com/

CitationBoominathan L, Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Lysophosphatidic acid (LPA), a phospholipid derivative that functions as a signalling molecule,  increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of  its target gene, 8/April/2017, 10.50 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.